Approval · Notice of Compliance 35659 · 2025
AMVUTTRA: Notice of Compliance 35659
Issued July 11, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35659
- Date
- July 11, 2025
- Company
- Alnylam Netherlands B.V.Amsterdam, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMVUTTRA | Not yet assigned | — |
Medicinal ingredients
- VUTRISIRAN SODIUM 25 MG per 0.5ML